Although BTMs, including osteocalcin, PINP, and β-CTX, are useful in assessing the bone turnover status in osteoporosis diagnosis and the subsequent therapy process, they may not be the best markers for early warning in patients with osteopenia. This evidence concerns the gene BGLAP and Osteopenia.